We are live on ! Find out more
CEP

Chicago Equity Partners Portfolio holdings

AUM $993M
1-Year Est. Return 6.42%
This Fund
S&P 500
This Quarter Est. Return
+1.82%
1 Year Est. Return
-6.42%
3 Year Est. Return
+34.83%
5 Year Est. Return
+90.28%
10 Year Est. Return
AUM
$3.13B
AUM Growth
-$148M
Cap. Flow
-$136M
Cap. Flow %
-4.34%
Top 10 Hldgs %
13.81%
Holding
856
New
126
Increased
232
Reduced
355
Closed
111

Top Sells

Rank Stock Value
1
DPZ icon
Domino's
DPZ
+$18.6M
2
BAX icon
Baxter International
BAX
+$15.5M
3
WTFC icon
Wintrust Financial
WTFC
+$14.9M
4
TROW icon
T. Rowe Price
TROW
+$14.8M
5
RITM icon
Rithm Capital
RITM
+$13.9M

Sector Composition

Rank Sector Weight
1 Financials 17.53%
2 Technology 15.8%
3 Industrials 14.47%
4 Healthcare 12.13%
5 Consumer Discretionary 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VER
526
DELISTED
VEREIT, Inc.
VER
$852K 0.03%
+24,490
New +$869K
POWI icon
527
Power Integrations
POWI
$3.15B
$845K 0.03%
24,740
-4,320
-15% -$154K
LAZ icon
528
Lazard
LAZ
$4B
$844K 0.03%
+16,065
New +$891K
BCC icon
529
Boise Cascade
BCC
$2.73B
$834K 0.03%
21,615
-655
-3% -$27.2K
HRTG icon
530
Heritage Insurance Holdings
HRTG
$903M
$830K 0.03%
54,720
CPT icon
531
Camden Property Trust
CPT
$11.5B
$828K 0.03%
9,840
-3,825
-28% -$319K
EXPO icon
532
Exponent
EXPO
$3.19B
$827K 0.03%
21,030
+2,180
+12% +$82.4K
NYT icon
533
New York Times
NYT
$12.6B
$821K 0.03%
+34,050
New +$782K
KERX
534
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$813K 0.03%
198,730
-144,305
-42% -$672K
SRPT icon
535
Sarepta Therapeutics
SRPT
$1.64B
$802K 0.03%
10,825
+535
+5% +$35.7K
TOWR
536
DELISTED
Tower International, Inc.
TOWR
$799K 0.03%
28,785
-835
-3% -$24K
MSM icon
537
MSC Industrial Direct
MSM
$6.76B
$783K 0.03%
+8,535
New +$788K
NTNX icon
538
Nutanix
NTNX
$16.1B
$782K 0.03%
15,925
+780
+5% +$30.9K
CHCO icon
539
City Holding Co
CHCO
$2.05B
$773K 0.02%
11,280
+55
+0.5% +$3.8K
CI icon
540
Cigna
CI
$78.4B
$772K 0.02%
4,605
+3,005
+188% +$584K
RH icon
541
RH
RH
$3.33B
$764K 0.02%
8,020
-4,815
-38% -$427K
ZTS icon
542
Zoetis
ZTS
$32.7B
$744K 0.02%
8,915
-5,380
-38% -$424K
TXRH icon
543
Texas Roadhouse
TXRH
$13.7B
$743K 0.02%
12,855
+1,370
+12% +$78.7K
NBIX icon
544
Neurocrine Biosciences
NBIX
$18.2B
$738K 0.02%
8,895
-26,660
-75% -$2.25M
CHRW icon
545
C.H. Robinson
CHRW
$20.5B
$736K 0.02%
7,855
HA
546
DELISTED
Hawaiian Holdings, Inc.
HA
$735K 0.02%
18,990
+3,440
+22% +$128K
PPLI
547
People Inc
PPLI
$3.12B
$720K 0.02%
25,767
-26,466
-51% -$697K
MUSA icon
548
Murphy USA
MUSA
$11.4B
$720K 0.02%
9,895
+215
+2% +$16.8K
ZAGG
549
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$718K 0.02%
58,875
+235
+0.4% +$3.66K
TLRD
550
DELISTED
Tailored Brands, Inc.
TLRD
$715K 0.02%
+28,530
New +$661K

Similar funds

Chicago Equity Partners's Q1 2018 Portfolio in Review

As of Q1 2018, Chicago Equity Partners held 856 positions worth $3.13B, down 4.5% from $3.28B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Chicago Equity Partners withdrew a net $136M in Q1 2018, closing 111 positions and reducing 355 holdings. Its most notable exit was Domino's, an estimated $18.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

Against the trend, Chicago Equity Partners opened a new position in Legg Mason, Inc. worth $14.9M.

  • Chicago Equity Partners's largest Q1 2018 buy was Legg Mason, Inc.: 366,965 shares worth $14.9M.
  • Chicago Equity Partners added most to Varian Medical Systems, Inc. in Q1 2018, an estimated $14.8M increase.
  • Chicago Equity Partners's biggest Q1 2018 reduction was Baxter International, cutting an estimated $15.5M.
  • Chicago Equity Partners fully exited Domino's in Q1 2018, selling an estimated $18.6M.
  • Chicago Equity Partners's ten largest holdings make up 14% of its $3.13B portfolio in Q1 2018.
  • Chicago Equity Partners opened 126 new positions and closed 111 in Q1 2018.
  • Chicago Equity Partners's portfolio value fell 4.5% quarter-over-quarter to $3.13B.

Based on Chicago Equity Partners's 13F filing for Q1 2018, filed 7 May 2018.